Understand the Opportunity

Independent thought leadership informed by intellectual rigour and investment expertise.
Filter

Electrification Sparks: Not Enough Supply

Record-breaking power auction prices highlight urgent need for more electrification investments to meet rising demand and improve grid infrastructure.

Quality During Times of Uncertainty

Learn how investing in quality companies with durable moats can offer resilience and long-term outperformance during times of market uncertainty.

International Durable Quality: Exploring The Potentially Winning Formula

Explore the benefits of investing in high-quality international stocks focusing on long-term sustainability & competitive advantages with Tema's ITOL ETF,

Digital Assets and Electrification

Digital assets i.e. crypto currencies continue to expand. Through price appreciation, new use cases, and institutionalization, digital assets are a growing part of the financial system.

Mission-Critical Businesses

Indispensable businesses provide mission-critical products. Learn why these companies are resilient, high-quality, and potentially strong investments.

Powering Made in America

Explore the resurgence of Made in America through reshoring, evolving trade policies, and electrification, unlocking investment opportunities in critical industries poised for growth.

The DSPY ETF: S&P 500 with Reduced Concentration Risk

Reduce S&P 500 concentration risk. Discover how DSPY’s historical-weight approach balances exposure, lowers single-stock risk, and preserves index core.

Tariffs & Reshoring

Explore the impact of Trump's tariffs on reshoring, manufacturing, and the reshaping of the US economy in this insightful analysis by Chris Semenuk.

AI and drug discovery: a slow evolution in cancer care

AI is revolutionizing cancer drug discovery, but progress is slow. Discover the latest advancements and upcoming breakthroughs from leading AI.

Tangible Durable Moat Stocks as Real Assets

Tema Monopolies and Oligopolies ETF (TOLL) , a fund investing in durable, tangible and dominant moat equities could act as a real asset.

Investing in the Electrification Megacycle

Explore the electrification megacycle's $7 trillion opportunity, driven by AI, EVs, and reindustrialization through Tema Electrification ETF (VOLT).

The Pursuit of an Oral Obesity Agent: Why Pills Matter

Exploring the shift from injectable to oral obesity medications and their potential to revolutionize weight loss treatments for broader market appeal and better patient convenience.

How is Reshoring Affecting Your State?

Discover how state level reshoring is transforming manufacturing in the U.S. with major investments in states like Arizona, Texas, New York, and Indiana.

Could Family Offices Build ETFs to Manage Tax and Concentration Concerns?

Discover how family offices can utilize ETFs to manage tax and concentration concerns in their portfolios while maximizing diversification.

Why Reshoring Beats Nearshoring for Supply Chain and Manufacturing Security

Reshoring to the US offers better supply chain security compared to nearshoring, which poses significant geopolitical and economic risks.

A new way to think about moats

Discover a new approach to investing by focusing on durable, tangible, and dominant moats for long-term stock performance.

American Reshoring and the U.S. Election

Discover key differences between ETFs & mutual funds. Learn what ETFs & mutual funds are, to decide which is better for your investment strategy.

More young people are getting cancer – does the industry have an answer?

Rising cancer rates among young adults demand better early detection. Blood-based screenings like Guardant's Shield offer hope.

What is Liquidity In ETFs? Key Insights & Importance

Learn what ETF liquidity is, why it matters, and how it affects trading. Discover factors influencing liquidity and how it impacts your investment returns.

Why pricing is not a risk to the GLP-1 market opportunity?

Learn why pricing is not a risk to the GLP-1 market opportunity. Discover the justified cost of weight loss drugs and their significant clinical benefits.

How big is the weight loss industry?

How big is the weight loss industry and how can you identify the risks and opportunities in this market

Five observations on ASCO 2024

Discover key insights from ASCO 2024, showcasing advancements in oncology therapeutics and diagnostics. Explore trends in ADCs, genomic profiling, immuno-oncology, targeted agents, and emerging modalities.

HRTS is the world’s first ETF investing in GLP-1, addressing obesity and cardiometabolic diseases

Discover Tema GLP-1, Obesity & Cardiometabolic ETF, the world's first ETF investing in GLP-1 for obesity and cardiometabolic diseases.

GLP-1 Pioneer Prof. Jens Juul Holst Joins Tema ETFs As A Scientific Advisor

Tema ETFs with Prof. Jens Juul Holst joining as a Scientific Advisor, bringing groundbreaking research in obesity and diabetes treatment.

Investing In The Fight Against Obesity: The Case For Active ETFs

Discover the importance of active management in investing in obesity and cardiometabolic trends, navigating risks and opportunities of the industry.

The Next 10 Weight-Loss Drugs: Life After GLP-1?

Explore the latest weight loss drug stocks with 10 new obesity medications, targeting GLP-1 alternatives, muscle sparing, and better tolerability.

Generating Investment Ideas

Discover our approach to generating investment ideas by defining a strategic universe, refining research sets, and sparking creativity for robust portfolio opportunities.

How to position a portfolio for the US election

Position your portfolio strategically for the upcoming US election by considering sector focus risks and foreign market investments.

Immuno-oncology’s Second Act

Discover the potential of immuno-oncology's second act with new approaches and targets like TIGIT and LAG3. These advancements revolutionize cancer treatment.

Radiopharmaceuticals: Transforming Cancer Care

Discover how radiopharmaceuticals are revolutionizing cancer care and how to invest in them.

Q4 2023 CIO Investor Update

Read about the market trends and outlook for 2024 in this CIO update.

Cell therapies - Revolutionizing Cancer Treatment

Revolutionize cancer treatment with cell therapies. Discover the potential impact on multiple myeloma and the growing oncology cell therapy market.

Tema's Active Investment Process

Learn about Tema’s active investment process, combining fundamental analysis and systematic strategies to optimize portfolios and manage risks effectively.

Artificial Intelligence (AI) and Incumbent Data Moats

Discover how artificial intelligence is disrupting the market and why data moats are becoming crucial for information service businesses.

The Next Generation of Cardiovascular Drugs

Discover the next generation of cardiovascular drugs and their potential to revolutionize the treatment of cardiovascular disease.

Private Sector Roots to Shine Through in an Election Year

Private sector companies are making independent decisions to reshore manufacturing operations as companies navigate global risks and supply chain stress.

Liquid Biopsies - Revolutionizing Cancer Diagnosis

Discover how liquid biopsies are revolutionizing cancer diagnosis and changing the landscape of cancer detection.

Valuation

Discover how to assess the valuation case for potential investments and the various approaches used to determine stock value.

Security Selection

Learn about security selection in investing and how to generate alpha by selecting the right stocks through fundamental research.

Tema Earnings Insights: Reshoring

Gain insights into the reshoring phenomenon and its impact on infrastructure, manufacturing and supply chain.

Tema Insights: Investor Guide to Oncology

Discover the latest trends and opportunities in the field of oncology investing.

The Competitive Techscape: Dispelling the Monopoly Narrative

Explore the competitive landscape of the technology sector and whether it can lead to monopolies.

Tema launches its second targeted healthcare fund: the Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS)

Cardiovascular and Metabolic ETF (HRTS) is a unique investment opportunity in the healthcare sector focused on obesity, diabetes, cardiovascular diseases.

Investing in the Obesity Epidemic: The Weight Loss Drug Revolution

Obesity ETF: A unique investment opportunity in the biotech and healthcare sector focused on obesity, diabetes, cardiovascular diseases.

Tema's Edge

Learn about informational, analytical, and behavioral edges in the investment process.

Investor's Guide to the Oncology Revolution Webinar Replay

Discover the exciting investment opportunities and challenges in cancer therapeutics and research in our latest webinar replay and research report.

Risk Management

Learn how Tema implements multi-layered risk management in investing risk management strategies to enhance investment outcomes.

Tema ETFs Portfolio Construction Process

Discover the optimal portfolio construction process to maximize alpha and avoid losses. Learn about position sizing, and portfolio management strategies.

Operating Base

Learn why a strong operating base is crucial for company success. Explore factors like product positioning, R&D, management, location, and business model.

Investing in oncology: a biotech revolution in research, diagnosis, and treatment of cancer

Investing in oncology: a biotech revolution in research, diagnosis, and treatment of cancer.

Tema launches actively managed oncology ETF: investing in the cancer life-science revolution

Tema ETFs (“Tema”) launches the Tema Oncology ETF (CANC), the first actively managed ETF listed in the United States seeking to provide long-term growth.

Balance Sheet and Cash Flow

Understanding the importance of balance sheets and cash flow-driven investing, the risks of weak financial metrics, the potential for value impairment.

Thematic ETFs: overcoming performance anxiety through purity of exposure

Overcome performance anxiety in thematic ETFs by focusing on purity of exposure.

Why American Reshoring extends beyond US infrastructure

Learn about the reshoring megatrend and how American manufacturing is being revitalized. Discover how you can invest in reshoring with the Tema American Reshoring ETF (RSHO).

Introduction to thematic investing

Learn how thematic investing targets long-term trends to drive growth and diversify portfolios. Discover strategies for identifying key investment themes.

Monopolies: how Tema seeks to identify and invest in moat-like businesses

Discover the benefits of investing in monopolies and moat-like businesses. Learn how to identify firms with strong barriers to entry for long-term returns.

Investing In Reshoring & American Manufacturing

Explore how reshoring could impact the US economy and drive investment opportunities

No results found